344 related articles for article (PubMed ID: 6230083)
61. In vitro activity of enoxacin compared with norfloxacin and amikacin.
van der Auwera P; de Moor G; Lacroix G; Mambour A; Rossion N; Schuyteneer F
Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568
[TBL] [Abstract][Full Text] [Related]
62. Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid.
Lumish RM; Norden CW
Antimicrob Agents Chemother; 1975 Feb; 7(2):159-63. PubMed ID: 1094949
[TBL] [Abstract][Full Text] [Related]
63. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
Salmon SA; Watts JL
Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
[TBL] [Abstract][Full Text] [Related]
64. Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.
Seibert G; Limbert M; Klesel N
Eur J Clin Microbiol; 1983 Dec; 2(6):548-53. PubMed ID: 6230226
[TBL] [Abstract][Full Text] [Related]
65. Comparative in vitro studies of cinoxacin, nalidixic acid, and oxolinic acid.
Gordon RC; Stevens LI; Edmiston CE; Mohan K
Antimicrob Agents Chemother; 1976 Dec; 10(6):918-20. PubMed ID: 12717
[TBL] [Abstract][Full Text] [Related]
66. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
Bauernfeind A; Petermüller C
Eur J Clin Microbiol; 1983 Apr; 2(2):111-5. PubMed ID: 6222896
[TBL] [Abstract][Full Text] [Related]
67. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1984 Mar; 25(3):319-26. PubMed ID: 6232895
[TBL] [Abstract][Full Text] [Related]
68. 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1H-pyrrol-1-yl)-quinoline-3-carb oxylic acid, a new fluorinated compounds of oxacin family with high broad-spectrum antibacterial activities.
Stefancich G; Artico M; Corelli F; Massa S; Panico S; Simonetti N
Farmaco Sci; 1985 Apr; 40(4):237-48. PubMed ID: 3926533
[TBL] [Abstract][Full Text] [Related]
69. Bactericidal effect against Escherichia coli of nalidixic acid and four structurally related compounds.
Stevens PJ
J Antimicrob Chemother; 1980 Jul; 6(4):535-42. PubMed ID: 6159344
[No Abstract] [Full Text] [Related]
70. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
Muytjens HL; van der Ros-van de Repe J; van Veldhuizen G
Antimicrob Agents Chemother; 1983 Aug; 24(2):302-4. PubMed ID: 6227281
[TBL] [Abstract][Full Text] [Related]
71. [In vitro antibacterial activity of a new fluoroquinolone, enoxacin against hospital bacteria and regression curve].
Soussy CJ; Cluzel M; Meyran M
Pathol Biol (Paris); 1995 Apr; 43(4):274-80. PubMed ID: 7567114
[TBL] [Abstract][Full Text] [Related]
72. Norfloxacin--a new antibacterial agent with anti-pseudomonal activity.
Peddie BA
N Z Med J; 1982 Oct; 95(717):712. PubMed ID: 6216426
[No Abstract] [Full Text] [Related]
73. In-vitro activity of pefloxacin compared with six other quinolones.
Ligtvoet EE; Wickerhoff-Minoggio T
J Antimicrob Chemother; 1985 Oct; 16(4):485-90. PubMed ID: 3864776
[TBL] [Abstract][Full Text] [Related]
74. In vitro selection of Escherichia coli mutants with decreased susceptibility to norfloxacin.
Forsgren A; Striby AC
Scand J Infect Dis; 1988; 20(5):531-4. PubMed ID: 3065926
[TBL] [Abstract][Full Text] [Related]
75. Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.
Khan MY; Gruninger RP; Nelson SM; Klicker RE
Antimicrob Agents Chemother; 1982 May; 21(5):848-51. PubMed ID: 6213200
[TBL] [Abstract][Full Text] [Related]
76. In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents.
Body BA; Fromtling RA; Shadomy S; Shadomy HJ
Eur J Clin Microbiol; 1983 Jun; 2(3):230-4. PubMed ID: 6224678
[TBL] [Abstract][Full Text] [Related]
77. Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715).
Shungu DL; Weinberg E; Gadebusch HH
Antimicrob Agents Chemother; 1983 Feb; 23(2):256-60. PubMed ID: 6220671
[TBL] [Abstract][Full Text] [Related]
78. The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria.
Corrado ML; Cherubin CE; Shulman M
J Antimicrob Chemother; 1983 Apr; 11(4):369-76. PubMed ID: 6222023
[TBL] [Abstract][Full Text] [Related]
79. [Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].
Thabaut A; Durosoir JL
Pathol Biol (Paris); 1982 Jun; 30(6):394-7. PubMed ID: 6810283
[TBL] [Abstract][Full Text] [Related]
80. Selective decontamination of the digestive tract by norfloxacin. A preliminary report.
Pecquet SS; Andremont AO; Tancrède CH
Prog Clin Biol Res; 1985; 181():255-8. PubMed ID: 3161086
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
